Abstract
Quinoxapeptin A and B are novel chromodepsipeptides which were isolated from a nocardioform actinomycete with indeterminant morphology. Quinoxapeptins A and B are potent inhibitors of HIV-1 and HIV-2 reverse transcriptase and almost equally active against two single mutants forms as well as a double mutant form of HIV-1 reverse transcriptase. Quinoxapeptin A and B are specific inhibitors of HIV-1 and HIV-2 reverse transcriptase because they did not inhibit human DNA polymerase alpha, beta, gamma and delta. Quinoxapeptin A and B are structurally similar to luzopeptin A which was also active against HIV-1 and HIV-2 reverse transcriptase.
MeSH terms
-
Actinomycetales / classification
-
Actinomycetales / metabolism
-
HIV Reverse Transcriptase
-
HIV-1 / enzymology*
-
HIV-1 / genetics
-
HIV-2 / enzymology*
-
Humans
-
Hydroxyquinolines / chemistry
-
Hydroxyquinolines / pharmacology
-
In Vitro Techniques
-
Kinetics
-
Molecular Structure
-
Mutation
-
Nucleic Acid Synthesis Inhibitors
-
Peptides, Cyclic / chemistry
-
Peptides, Cyclic / metabolism*
-
Peptides, Cyclic / pharmacology*
-
Quinoxalines / chemistry
-
Quinoxalines / metabolism*
-
Quinoxalines / pharmacology*
-
RNA-Directed DNA Polymerase / genetics
-
RNA-Directed DNA Polymerase / metabolism*
-
Reverse Transcriptase Inhibitors / chemistry
-
Reverse Transcriptase Inhibitors / metabolism*
-
Reverse Transcriptase Inhibitors / pharmacology*
Substances
-
Hydroxyquinolines
-
Nucleic Acid Synthesis Inhibitors
-
Peptides, Cyclic
-
Quinoxalines
-
Reverse Transcriptase Inhibitors
-
quinoxapeptin A
-
quinoxapeptin B
-
BBM-928 A
-
reverse transcriptase, Human immunodeficiency virus 2
-
HIV Reverse Transcriptase
-
RNA-Directed DNA Polymerase